CW July 2004

category image Volume 13
Issue Number 7
July 2004
ISSN 10593802

Tulane Offers Clinical Trial for Lung Cancer Vaccine

The Tulane Cancer Center is the first site in the country and the only site in the Gulf South to offer a Southwest Oncology Group (SWOG) phase II clinical trial for a vaccine to fight a particular type of lung cancer, bronchoalveolar carcinoma (BAC).
Go to Previous Page
Go to Next Page

Source & Additional Reading

Raja Mudad, a hematologist/medical oncologist at Tulane and a lead investigator in this national study.

For more information on this lung cancer vaccine trial, contact the Tulane Cancer Center?s Office of Clinical Research at (504) 585-6121.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW July 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login

Mountain Media ecommerce solutions Ecommerce Solutions by Mountain Media